Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

In an exclusive interview, Anne and Janet Wojcicki share how their family is working to raise awareness and fund research ...

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

The president-elect selected Dr. Jay Bhattacharya, a medical doctor and economist known as a harsh critic of public health agencies’ response to the Covid-19 pandemic, for the job.

Concerns have been raised by senior doctors surrounding the misuse of weight-loss pens in the UK, with some patients ...

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...

Amgen's MariTide shows promising weight loss results in Phase II for type 2 diabetes. Find out why AMGN stock remains as a strong buy for long-term investors.

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

The Biden administration has announced a new proposal to include weight-loss drugs under Medicare and Medicaid programmes. While the plan will help more than seven million Americans struggling with ...

U.S. GDP data shows economy expanding at healthy clip: The latest read on the U.S. economy this morning shows the country’s gross domestic product expanding at a 2.8 per cent annual pace in the third ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...